Fda warning letters

Anticipating FDA
Warning Letters?
WHAT IS A WARNING LETTER?
A Warning Letter is
issued by the FDA to a
regulated manufacturer
if it is found that any
significant regulatory
violations have
occurred.
Nonconformance with
Good Manufacturing
Practices (GMP)
False Claims About a
Product
Inadequate Training
for Personnel
Wrong directions for
Use and so on…
Violations Identified in Warning
Letters Include-
FDA Has Been Busy! (2000-2015)
300000+
Inspections
170000+
Facilities
130000+
483S
4500+
Inspectors
Fda  warning letters
What Are The Trends?
WatchOutforWarningLetterSigns
• Long standing internal problems that
have not yet caught the attention of
the FDA but are known within the
company
• Form 483 notifications (the most
obvious predictor of Warning Letters)
• Red flags from the Quality Unit
• Adverse events
• High volume of customer complaints
• Prior investigations about the same
issue or same type of issue
• FDA responses to communications
from the company that do not signal
satisfaction with issue resolution and
so on
• Product contamination
• Off-Label Promotional activities that
have caught the attention of the FDA
• DDMAC letters
• Repeated FDA inspections of facilities
For more on FDA Compliance
Visit our Website
www.complianceonline
FDA Compliance
Thankyou !
1 von 8

Recomendados

FDA Warning Letter von
FDA Warning LetterFDA Warning Letter
FDA Warning LetterCompliance Insight, Inc.
4.6K views20 Folien
Form483 warning letter issued to pharmaceutical companies by Bindu Kshtriya von
Form483 warning letter issued to pharmaceutical companies by Bindu KshtriyaForm483 warning letter issued to pharmaceutical companies by Bindu Kshtriya
Form483 warning letter issued to pharmaceutical companies by Bindu KshtriyaBindu Kshtriya
1.5K views7 Folien
Mock Response to a FDA Warning Letter von
Mock Response to a FDA Warning LetterMock Response to a FDA Warning Letter
Mock Response to a FDA Warning Lettermuna_ali
5.2K views7 Folien
FDA 483 von
FDA 483FDA 483
FDA 483Compliance Insight, Inc.
3.2K views14 Folien
Responding Effectively to FDA 483 Observations & Warning Letters von
Responding Effectively to FDA 483 Observations & Warning LettersResponding Effectively to FDA 483 Observations & Warning Letters
Responding Effectively to FDA 483 Observations & Warning LettersMaetrics
6.1K views50 Folien
Writing an Effective 483 response von
Writing an Effective 483 responseWriting an Effective 483 response
Writing an Effective 483 responseKiran Kota
703 views18 Folien

Más contenido relacionado

Was ist angesagt?

How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters von
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersHow to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersGreenlight Guru
1.4K views36 Folien
Fda Inspection von
Fda InspectionFda Inspection
Fda InspectionCompliance Insight, Inc.
7.2K views21 Folien
Excipient Auditing von
Excipient AuditingExcipient Auditing
Excipient AuditingJohn E. Osani
1.4K views42 Folien
Corrective Action & Preventive Action von
Corrective Action & Preventive ActionCorrective Action & Preventive Action
Corrective Action & Preventive ActionGMP EDUCATION : Not for Profit Organization
52.5K views50 Folien
Deviation and root cause analysis in Pharma von
Deviation and root cause analysis in PharmaDeviation and root cause analysis in Pharma
Deviation and root cause analysis in PharmaSubhash Sanghani
20.2K views7 Folien
Pravin von
PravinPravin
PravinPravin Jadhao
455 views16 Folien

Was ist angesagt?(20)

How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters von Greenlight Guru
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersHow to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
Greenlight Guru1.4K views
Deviation and root cause analysis in Pharma von Subhash Sanghani
Deviation and root cause analysis in PharmaDeviation and root cause analysis in Pharma
Deviation and root cause analysis in Pharma
Subhash Sanghani20.2K views
The Role of Regulatory GMP Audit in Pharmaceutical Companies. von Jitendra Sonawane
The Role of Regulatory GMP Audit in Pharmaceutical Companies.The Role of Regulatory GMP Audit in Pharmaceutical Companies.
The Role of Regulatory GMP Audit in Pharmaceutical Companies.
Jitendra Sonawane5.1K views
corrective and preventive action (CAPA) von prakhar rai pk
corrective and preventive action (CAPA)corrective and preventive action (CAPA)
corrective and preventive action (CAPA)
prakhar rai pk1.1K views
quality assurance audits von rasikawalunj
quality assurance audits quality assurance audits
quality assurance audits
rasikawalunj3.7K views
75 min presentation in program organized by Gudia (Pvt.) Ltd Pakistan & Dr. P... von Obaid Ali / Roohi B. Obaid
75 min presentation in program organized by Gudia (Pvt.) Ltd Pakistan & Dr. P...75 min presentation in program organized by Gudia (Pvt.) Ltd Pakistan & Dr. P...
75 min presentation in program organized by Gudia (Pvt.) Ltd Pakistan & Dr. P...
Managing non conformities through , how to reduce element that lowers quality von chakalisa chicho
Managing non conformities through , how to reduce element that lowers qualityManaging non conformities through , how to reduce element that lowers quality
Managing non conformities through , how to reduce element that lowers quality
chakalisa chicho1.8K views
Biopharmaceutical manufacturing instrument classification von Denny Walthers
Biopharmaceutical manufacturing instrument classificationBiopharmaceutical manufacturing instrument classification
Biopharmaceutical manufacturing instrument classification
Denny Walthers400 views
CAPA Management | What is CAPA? | Corrective And Preventive Action von Anil Chaudhari
CAPA Management | What is CAPA? | Corrective And Preventive ActionCAPA Management | What is CAPA? | Corrective And Preventive Action
CAPA Management | What is CAPA? | Corrective And Preventive Action
Anil Chaudhari1.7K views
60 min talk in program organized by Gudia (Pvt.) Ltd Pakistan & Dr. Pharm, China von Obaid Ali / Roohi B. Obaid
60 min talk in program organized by Gudia (Pvt.) Ltd Pakistan & Dr. Pharm, China60 min talk in program organized by Gudia (Pvt.) Ltd Pakistan & Dr. Pharm, China
60 min talk in program organized by Gudia (Pvt.) Ltd Pakistan & Dr. Pharm, China

Similar a Fda warning letters

FDA warning letter-Quick Review-India von
FDA warning letter-Quick Review-IndiaFDA warning letter-Quick Review-India
FDA warning letter-Quick Review-IndiaTech Observer
383 views27 Folien
Regulatory 101 for Medical Device Start Ups von
Regulatory 101 for Medical Device Start UpsRegulatory 101 for Medical Device Start Ups
Regulatory 101 for Medical Device Start UpsEMMAIntl
26 views23 Folien
About Compliance Insight Inc. von
About Compliance Insight Inc.About Compliance Insight Inc.
About Compliance Insight Inc.Compliance Insight, Inc.
1.3K views20 Folien
9 regulatory compliance and validation for li von
9 regulatory compliance and validation for li9 regulatory compliance and validation for li
9 regulatory compliance and validation for liWebseology
1K views54 Folien
Quality Considerations in Due Diligence for Pharmaceutical Transactions von
Quality Considerations in Due Diligence for Pharmaceutical TransactionsQuality Considerations in Due Diligence for Pharmaceutical Transactions
Quality Considerations in Due Diligence for Pharmaceutical TransactionsMichael Swit
507 views26 Folien
WHAT IS GMP CERTIFICATION? von
WHAT IS GMP CERTIFICATION?WHAT IS GMP CERTIFICATION?
WHAT IS GMP CERTIFICATION?Rishabhparihar8
21 views4 Folien

Similar a Fda warning letters(20)

FDA warning letter-Quick Review-India von Tech Observer
FDA warning letter-Quick Review-IndiaFDA warning letter-Quick Review-India
FDA warning letter-Quick Review-India
Tech Observer383 views
Regulatory 101 for Medical Device Start Ups von EMMAIntl
Regulatory 101 for Medical Device Start UpsRegulatory 101 for Medical Device Start Ups
Regulatory 101 for Medical Device Start Ups
EMMAIntl26 views
9 regulatory compliance and validation for li von Webseology
9 regulatory compliance and validation for li9 regulatory compliance and validation for li
9 regulatory compliance and validation for li
Webseology1K views
Quality Considerations in Due Diligence for Pharmaceutical Transactions von Michael Swit
Quality Considerations in Due Diligence for Pharmaceutical TransactionsQuality Considerations in Due Diligence for Pharmaceutical Transactions
Quality Considerations in Due Diligence for Pharmaceutical Transactions
Michael Swit507 views
Handling of a fda inspection [compatibility mode] von Kiran Kota
Handling of a fda inspection [compatibility mode]Handling of a fda inspection [compatibility mode]
Handling of a fda inspection [compatibility mode]
Kiran Kota893 views
FDA Inspections - Lessons Learnt von VISAMED GmbH
FDA Inspections - Lessons LearntFDA Inspections - Lessons Learnt
FDA Inspections - Lessons Learnt
VISAMED GmbH1.7K views
Indian GMP Certification & WHO GMP Certification von Vishal Shelke
Indian GMP Certification & WHO GMP CertificationIndian GMP Certification & WHO GMP Certification
Indian GMP Certification & WHO GMP Certification
Vishal Shelke11.5K views
How to establish and maintain a great working (3)) von Jerome Gainer
How to establish and maintain a great working (3))How to establish and maintain a great working (3))
How to establish and maintain a great working (3))
Jerome Gainer146 views
Regulatory & Quality Considerations in Virtual Drug Development von Michael Swit
Regulatory & Quality Considerations in Virtual Drug DevelopmentRegulatory & Quality Considerations in Virtual Drug Development
Regulatory & Quality Considerations in Virtual Drug Development
Michael Swit62 views
Pharmi Med Ltd Brochure Short von ADNAN ASHFAQ
Pharmi Med Ltd Brochure ShortPharmi Med Ltd Brochure Short
Pharmi Med Ltd Brochure Short
ADNAN ASHFAQ139 views

Más de complianceonline123

Fda adverse event reporting requirements for otc drugs von
Fda adverse event reporting requirements  for otc drugsFda adverse event reporting requirements  for otc drugs
Fda adverse event reporting requirements for otc drugscomplianceonline123
1K views10 Folien
Social media risks rules policies procedures von
Social media risks rules policies  proceduresSocial media risks rules policies  procedures
Social media risks rules policies procedurescomplianceonline123
474 views11 Folien
Fmla ada overlap von
Fmla  ada  overlapFmla  ada  overlap
Fmla ada overlapcomplianceonline123
929 views14 Folien
Hipaa enforcement examples von
Hipaa enforcement examplesHipaa enforcement examples
Hipaa enforcement examplescomplianceonline123
362 views9 Folien
Excel spreadsheets how to ensure 21 cfr part 11 compliance von
Excel spreadsheets  how to ensure 21 cfr part 11 complianceExcel spreadsheets  how to ensure 21 cfr part 11 compliance
Excel spreadsheets how to ensure 21 cfr part 11 compliancecomplianceonline123
6.3K views8 Folien
Retail loss von
Retail lossRetail loss
Retail losscomplianceonline123
1.3K views18 Folien

Más de complianceonline123(20)

Fda adverse event reporting requirements for otc drugs von complianceonline123
Fda adverse event reporting requirements  for otc drugsFda adverse event reporting requirements  for otc drugs
Fda adverse event reporting requirements for otc drugs
Excel spreadsheets how to ensure 21 cfr part 11 compliance von complianceonline123
Excel spreadsheets  how to ensure 21 cfr part 11 complianceExcel spreadsheets  how to ensure 21 cfr part 11 compliance
Excel spreadsheets how to ensure 21 cfr part 11 compliance
complianceonline1236.3K views
Out in the open protecting your privacy in the digital age von complianceonline123
Out in the open  protecting your privacy in the digital ageOut in the open  protecting your privacy in the digital age
Out in the open protecting your privacy in the digital age
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potential von complianceonline123
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s PotentialReaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potential
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potential
Audit Process: How to Successfully Plan Audit von complianceonline123
Audit Process: How to Successfully Plan Audit Audit Process: How to Successfully Plan Audit
Audit Process: How to Successfully Plan Audit
complianceonline1231.1K views

Último

Nitrosamine & NDSRI.pptx von
Nitrosamine & NDSRI.pptxNitrosamine & NDSRI.pptx
Nitrosamine & NDSRI.pptxNileshBonde4
18 views22 Folien
application of genetic engineering 2.pptx von
application of genetic engineering 2.pptxapplication of genetic engineering 2.pptx
application of genetic engineering 2.pptxSankSurezz
12 views12 Folien
CSF -SHEEBA.D presentation.pptx von
CSF -SHEEBA.D presentation.pptxCSF -SHEEBA.D presentation.pptx
CSF -SHEEBA.D presentation.pptxSheebaD7
14 views13 Folien
POSTER IV LAWCN_ROVER_IUE.pdf von
POSTER IV LAWCN_ROVER_IUE.pdfPOSTER IV LAWCN_ROVER_IUE.pdf
POSTER IV LAWCN_ROVER_IUE.pdfSOCIEDAD JULIO GARAVITO
11 views1 Folie
ALGAL PRODUCTS.pptx von
ALGAL PRODUCTS.pptxALGAL PRODUCTS.pptx
ALGAL PRODUCTS.pptxRASHMI M G
5 views17 Folien
Pollination By Nagapradheesh.M.pptx von
Pollination By Nagapradheesh.M.pptxPollination By Nagapradheesh.M.pptx
Pollination By Nagapradheesh.M.pptxMNAGAPRADHEESH
17 views9 Folien

Último(20)

application of genetic engineering 2.pptx von SankSurezz
application of genetic engineering 2.pptxapplication of genetic engineering 2.pptx
application of genetic engineering 2.pptx
SankSurezz12 views
CSF -SHEEBA.D presentation.pptx von SheebaD7
CSF -SHEEBA.D presentation.pptxCSF -SHEEBA.D presentation.pptx
CSF -SHEEBA.D presentation.pptx
SheebaD714 views
Pollination By Nagapradheesh.M.pptx von MNAGAPRADHEESH
Pollination By Nagapradheesh.M.pptxPollination By Nagapradheesh.M.pptx
Pollination By Nagapradheesh.M.pptx
MNAGAPRADHEESH17 views
Applications of Large Language Models in Materials Discovery and Design von Anubhav Jain
Applications of Large Language Models in Materials Discovery and DesignApplications of Large Language Models in Materials Discovery and Design
Applications of Large Language Models in Materials Discovery and Design
Anubhav Jain11 views
Small ruminant keepers’ knowledge, attitudes and practices towards peste des ... von ILRI
Small ruminant keepers’ knowledge, attitudes and practices towards peste des ...Small ruminant keepers’ knowledge, attitudes and practices towards peste des ...
Small ruminant keepers’ knowledge, attitudes and practices towards peste des ...
ILRI5 views
Experimental animal Guinea pigs.pptx von Mansee Arya
Experimental animal Guinea pigs.pptxExperimental animal Guinea pigs.pptx
Experimental animal Guinea pigs.pptx
Mansee Arya28 views
Study on Drug Drug Interaction Through Prescription Analysis of Type II Diabe... von Anmol Vishnu Gupta
Study on Drug Drug Interaction Through Prescription Analysis of Type II Diabe...Study on Drug Drug Interaction Through Prescription Analysis of Type II Diabe...
Study on Drug Drug Interaction Through Prescription Analysis of Type II Diabe...
별헤는 사람들 2023년 12월호 전명원 교수 자료 von sciencepeople
별헤는 사람들 2023년 12월호 전명원 교수 자료별헤는 사람들 2023년 12월호 전명원 교수 자료
별헤는 사람들 2023년 12월호 전명원 교수 자료
sciencepeople50 views
How to be(come) a successful PhD student von Tom Mens
How to be(come) a successful PhD studentHow to be(come) a successful PhD student
How to be(come) a successful PhD student
Tom Mens513 views
Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositio... von Trustlife
Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositio...Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositio...
Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositio...
Trustlife18 views
Conventional and non-conventional methods for improvement of cucurbits.pptx von gandhi976
Conventional and non-conventional methods for improvement of cucurbits.pptxConventional and non-conventional methods for improvement of cucurbits.pptx
Conventional and non-conventional methods for improvement of cucurbits.pptx
gandhi97620 views

Fda warning letters

  • 2. WHAT IS A WARNING LETTER? A Warning Letter is issued by the FDA to a regulated manufacturer if it is found that any significant regulatory violations have occurred.
  • 3. Nonconformance with Good Manufacturing Practices (GMP) False Claims About a Product Inadequate Training for Personnel Wrong directions for Use and so on… Violations Identified in Warning Letters Include-
  • 4. FDA Has Been Busy! (2000-2015) 300000+ Inspections 170000+ Facilities 130000+ 483S 4500+ Inspectors
  • 6. What Are The Trends?
  • 7. WatchOutforWarningLetterSigns • Long standing internal problems that have not yet caught the attention of the FDA but are known within the company • Form 483 notifications (the most obvious predictor of Warning Letters) • Red flags from the Quality Unit • Adverse events • High volume of customer complaints • Prior investigations about the same issue or same type of issue • FDA responses to communications from the company that do not signal satisfaction with issue resolution and so on • Product contamination • Off-Label Promotional activities that have caught the attention of the FDA • DDMAC letters • Repeated FDA inspections of facilities
  • 8. For more on FDA Compliance Visit our Website www.complianceonline FDA Compliance Thankyou !